Abstract
Fundamental to the complex process associated with drug discovery is the establishment of a carefully defined collaborative relationship between academic bioorganic chemists and cellular or molecular pharmacologists. We mention this as a new emerging direction in research that should be particularly emphasized in an academic setting. The collaborative goal of the academic chemists and pharmacologists should be to contribute in some specific way to the advancement of each other’s science. Educational goals are not served well through routine programs for isolating and screening natural products. Screening programs of this kind are well developed in U.S. and foreign drug companies. In fact, new molecular receptor assays that allow a wide variety and large number of screens to be executed rapidly are becoming available. Academic pharmacologists have the responsibility to develop knowledge fundamental to advancing biomedical science by using bioactive substances as probes to better understand normal and pathological biological processes, to define in rigorous fashion the properties of these probes, and to determine their biochemical limitations and how they can be used properly and safely.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, T. J., 1990, The effects of manganese and changes in internal calcium on Na+—Ca+ exchange fluxes in the intact squid giant axon, Biochim. Biophys. Acta 1030: 101–110.
Bauer, F. W, van der Kerkhof, P. C., and Massen-de Grood, R. M., 1986, Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4, Br. J. Dermatol. 114: 409–412.
Beck, W. T., 1987, The cell biology of multiple drug resistance, Biochem. Pharmacol. 36 (18): 2879–2887.
Bellamy, W. T, Dalton, W. S., Kailey, J. M., Gleason, M. C., McCloskey, T. M., Dorr, R. T, and Alberts, D. S., 1988, Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage, Cancer Res. 48 (22): 6365–6370.
Biedler, J. L., and Meyers, M. B., 1989, Multidrug resistance (vinca alkaloids, actinomycin D, and anthracycline antibiotics), Drug Resist. Mamm. Cell 2: 57–58.
Bonney, R. J., Wightman, P. D., Dahlgren, M. E., Davies, P., Kuehl, F. A., and Humes, J., 1980, Effect of RNA and protein synthesis inhibitors on the release of inflammatory mediators by macrophages responding to phorbol myristate acetate, Biochim. Biophys. Acta 633: 410–421.
Burgess, J. R., de la Rosa, R. I., Jacobs, R. S., and Butler, A., 1991, A new eicosapentaenoic acid formed from arachidonic acid in the coralline red algae Bossiella orbigniana, Lipids 26: 162–165.
Busselberg, D., Evans, M. L., Rahmann, H., and Carpenter, D., 1991, Lead and zinc block a voltage-activated calcium channel of Aplysia neuron, J. Neurophysiol. 65: 786–795.
Bruno, N. A., Carver, L. A., and Slate, D. L., 1990, Isolation and characterization of doxorubicinresistant Lewis lung carcinoma variants, Cancer Commun. 2 (4): 151–158.
Calignano, A., Piomelli, D., Sacktor, T. C., and Swartz, J. H., 1991, A phospholipase A2 stimulating protein regulated by protein kinase C in Aplysia neurons, Brain Res. Mol. Brain Res. 9 (4): 347–351.
Center, M. S., 1988, Mechanisms regulating cell resistance to adriamycin, Biochem. Pharmacol. 34: 1471–1476.
Chan, H. S., Bradley, G., Thorner, P, Haddad, G., Gallie, B. L., and Ling, V, 1988, Methods in laboratory investigation: A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian-carcinoma cell-lines, Lab. Invest. 59 (6): 870–875.
Cimino, G., De Stefano, S., and Minale, L., 1974, Scalaradial, a third sesterterpene with the tetracarbocyclic skeleton of scalarin, from the sponge Cacospongia mollior, Experientia 30: 846–847.
Culver, P, and Jacobs, R. S., 1981, Lophotoxin: A neuromuscular toxin from the sea whip (Lophogorgia rigida), Toxicon 6: 825–830.
De Carvahlo, M. S., and Jacobs, R. S., 1991, Two step inactivation of bee venom PLA2 by scalardial, J. Biochem. Pharmacol. 42 (B): 1621–1626.
De Freitas, J. C., Blankemeier, L. A., and Jacobs, R. S., 1984, In vitro inactivation of the neurotoxic action of 3-bungarotoxin by the marine natural product, manoalide, Experientia 40(7):864–865.
Degnan, B. M., Hawkins, C. J., Lavin, M. F., McCaffrey, E. J., Parry, C. L., Vandenbrenk, A. L., and Wafters, D. J., 1989a, New cyclic-peptides with cyto-toxic activity from the ascidian LissoclinumPatella, J. Med. Chem. 32 (6): 1349–1354.
Degnan, B. M., Hawkins, C. J., Lavin, M. F., McCaffrey, E. J., Parry, C. L., and Wafters, D. J., 1989b, Novel cyto-toxic compounds from the ascidian Lissoclinum-Bistratum, J. Med. Chem. 32 (6): 1354–1359.
Dixon, R. A., Diehl, R. E., Opas, E. E., Rands, E., Vickers, P. J., Evans, J. F, Gillard, J. W, and Miller, D. K., 1990, Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis, Nature 343: 282–284.
Escalante, B., Erlij, D., Falck, J. R., and McGiff, J. C., 1991, Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle, Science 251: 799–802.
Ettouati, W. S., and Jacobs, R. S., 1987, Effect of pseudopterosin A on cell division, cell cycle progression, DNA, and protein synthesis in cultured sea urchin embryos, Mol. Pharmacol. 31: 500–505.
Fenical, W, Okuda, R. K., Bandurraga, M. M., Culver, P., and Jacobs, R. S., 1981, Lophotoxin: A novel neuromuscular toxin from Pacific sea whips of the genus Lophogorgia, Science 212: 1512.
Fishman, H. M., and Lipicky, R. J., 1991, Determination of K+-channel relaxation times in squid axon membranes by Hodgkin—Huxley and direct linear analysis, Biophys. Chem. 39: 177–190.
Ford, J. M., and Hait, W. N., 1990, Pharmacology of drugs that alter multidrug resistance in cancer, Pharmacol. Rev. 42: 155–190.
Fox, G. W., Kriebel, M. E., and Pappas, G. D., 1990, Morphological, physiological and biochemical observation on skate electric organ, Anat. Embryol. 18: 305–315.
Ghiara, P., Meli, T., Parente, L., and Persico, P, 1984, Distinct inhibition of membrane bound and lysosomal phospholipase A2 by glucocorticoid-induced proteins, Biochem. Pharmacol. 33: 1445–1450.
Glaser, K. B., and Jacobs, R. S., 1986, Molecular pharmacology of manoalide; inactivation of bee venom phospholipase A2, Biochem. Pharmacol. 35: 449–453.
Glaser, K. B., de Carvalho, M. S., Jacobs, R. S., Kernan, M. R., and Faulkner, D. J., 1989, Manoalide: Structure—activity studies and definition of the pharmacophore for phospholipase A2 inactivation, Mol. Pharmacol. 36: 782–788.
Goodman Gilman, A., Goodman, S. S., Rall, W. T., and Murad, F., 1985, The Pharmacological Basis of Therapeutics, 7th ed., Macmillan, New York.
Gottesman, M. M., 1988, Multidrug resistance during chemical carcinogenesis: A mechanism revealed, J. Natl. Cancer Inst. 80 (17): 1352–1353.
Hermanowicz, A., Gibson, P. R., and Jewell, D. P., 1985, The role of phagocytes in inflammatory bowel disease, Clin. Sci. 69: 2241–2249.
Huet, S., and Robert, J., 1988, The reversal of doxorubicin resistance by verapamil is not due to an effect on calcium channels, Int. J. Cancer 41 (2): 283–286.
Kernan, M. R., Faulkner, D. J., Parkanyi, L., Clardy, J., de Carvalho, M. S., and Jacobs, R. S., 1989, Luffolide, a novel anti-inflammatory terpene from the sponge Luffariella sp., Experientia 45: 388–390.
Kessel, D., and Wilberding, C., 1984, Mode of action of calcium antagonists which alter anthracycline resistance, Biochem. Pharmacol. 33 (7): 1157–1160.
Lewis, R. A., and Austen, K. F.,1984, The biologically active leukotrienes: Biosynthesis, metabolism, receptors, functions, and pharmacology, J. Clin. Invest. 73: 889–897.
Look, S. A., Fenical, W, Jacobs, R. S., and Clardy, J., 1986, The pseudopterosins: Anti-inflammatory and analgesic natural products from the sea whip Pseudopterogorgia elisabethae, Proc. Natl. Acad. Sci. USA 83: 6238–6240.
Melancon, M. J., Yeo, S. E., and Lech, J., 1986, Induction of hepatic microsomal monooxygenase activity in fish by exposure to river water, Environmental Toxicology and Chemistry 6: 127–135.
Moghaddam, M. F, Gerwick, W. H., and Ballantine, D. L., 1990, Discovery of the mammalian insulin release modulator, hepoxilin B3, from the tropical red algae Platysiphonia miniata and Cottoniella filamentosa, J. Biol. Chem. 265: 6126–6130.
O’Brien, E. T., Asai, D. J., Groweiss, A., Lipshutz, B. H., Fenical, W, Jacobs, R. S., and Wilson, L., 1986, Mechanism of action of the marine natural product stypoldione: Evidence for reaction with sulfhydryl groups, J. Med. Chem. 29: 1829–1851.
Ozols, R. F., Cunnion, R. E., Klecker, R. W, Hamilton, T. C., Ostchega, Y., Parrillo, J. E., and Young, R. C., 1987, Verapamil and adriamycin in the treatment of drug-resistant ovarian-cancer patients, J. Clin. Oncol. 5 (4): 641–647.
Pastan, I., Gottesman, M., Kahn, C. R., Flier, J., and Eder, P., 1987, Multiple-drug resistance in human cancer, N. Engl. J. Med. 316 (22): 1388–1393.
Piomelli, D., 1991, Metabolism of arachidonic acid in the nervous system of marine mollusk, Aplysia californic, Am. J. Physiol. 260 (5Pt2): R844–848.
Raz, A., Wyche, A., and Needleman, P., 1989, Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases, Proc. Natl. Acad. Sci. USA 86: 1657–1661.
Rouzer, C. A., Matsumoto, T., and Samuelsson, B., 1986, Single protein from human leukocytes possesses 5-lipoxygenase and leukotriene A4 synthase activities, Proc. Natl. Acad. Sci. USA 83: 857–861.
Schlondorff, D., Petty, E., Oates, J. A., Jacoby, M., and Levine, S. D., 1987, Epoxygenase metabolites of arachidonic acid inhibit vasopressin response in toad bladder, Am. J. Physiol. 253: F464 - F470.
Schwartzman, M. L., Balazy, M., Masferrer, J., Abraham, N. G., McGiff, J. C., and Murphy, R. C., 1987, 12 (R)-hydroxyicosatetraenoic acid: A cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea, Proc. Natl. Acad. Sci. USA 84: 8125–8129.
Staats, J., Marquardt, D., and Center, M. S., 1990, Characterization of a membrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates p-glycoprotein, J. Biol. Chem. 265: 4084 4090.
Stegeman, J. J., and Lech, J., 1991, P-450 monooxygenase systems in aquatic species: Carcinogen metabolism and biomarkers for carcinogen and pollutant exposure, Environmental Health Perspectives 90: 101–190.
Vane, J. R., 1971, Inhibition of prostaglandin synthesis as a mechanism for aspirin-like drugs, Nature New Biol. 231 (25): 232–235.
Werns, S. W, and Lucchessi, B. R., 1987, Inflammation and myocardial infarction, Br. Med. Bull. 43: 460–471.
Wijkander, J., and Sundler, R. A., 1989, A phospholipase A2 hydrolyzing arachidonyl-phospholipids in mouse peritoneal macrophages, FEBS Leu. 244: 51–56.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jacobs, R.S., Bober, M.A., Pinto, I., Williams, A.B., Jacobson, P.B., de Carvalho, M.S. (1993). Pharmacological Studies of Novel Marine Metabolites. In: Attaway, D.H., Zaborsky, O.R. (eds) Pharmaceutical and Bioactive Natural Products. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2391-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2391-2_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2393-6
Online ISBN: 978-1-4899-2391-2
eBook Packages: Springer Book Archive